long intergenic non-protein coding RNA 2476Genealiases: LVCAT5 · lnc-TSPAN12
Q-omics provides the consensus-scored LINC02476 profile across patient tissues and cancer cell-line models. LINC02476 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, LINC02476 is differentially expressed in 1, with the highest sampling consensus in LIHC. Additionally, LINC02476 RNA expression shows 5,614 significant pathway-activity associations, with the highest sampling consensus in UCEC. Together, these results highlight KIRC, LIHC, and UCEC as cancer lineages where LINC02476 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02476 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02476 survival associations across molecular data types. LINC02476 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02476 RNA expression–survival associations across cancer types. High LINC02476 expression shows unfavorable associations in KIRC, KIRP, MESO and KICH, but favorable associations in OV and LUAD. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .002). Together, the overview and detailed table identify KIRC as the clearest survival context for LINC02476 RNA expression.
This table summarizes LINC02476 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in LIHC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02476. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02476 shows higher tumor expression in LIHC. The LIHC box plot shows higher LINC02476 RNA expression in tumor versus normal tissue (log2 FC = +1.010, t-test p < 0.001).
This table shows molecular features associated with LINC02476 in patient tissues and cancer cell lines. In patient samples, LINC02476 shows the broadest associations at the RNA and protein expression levels, with UCEC recurring as the lineage with the largest associated feature set.
